Moolec Science SA Ordinary Shares(MLEC)
USD --+0.00%
Reward44Moderate
Risk74High
📊75%Data
Revenue growing 948% YoY
MLEC
+0.0 · +0.00%
USD · NASDAQ
Moolec Science SA Ordinary Shares | Healthcare
Capital Destroyer
Market Cap:11.71M
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
74
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MLEC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $3.00.

What is Moolec Science SA Ordinary Shares?

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally.

MLEC · Verdict

Moderate reward · high risk

MLEC's standout is volatility; balance sheet and profitability weigh on the picture.

Based on 88% data coverage

MLEC · Verdict

What’s working & what to watch

Strengths 1

  • Volatility75/100

    Above average

Watchouts 3

  • Balance sheet6/100

    Current ratio 0.13

  • Profitability9/100

    -33% net margin · -175% ROE

  • Cash flow12/100

    -9% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Moolec Science SA Ordinary Shares?

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 11.71M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap11.71M
P/E RatioN/A
Dividend YieldN/A
52 Week High157.05
52 Week Low3.075
Last AnnualJune
IPO Date1/3/2023
IncorporatedUSA
Shares Outstanding726K
No. of EmployeesN/A
IndustryBiotechnology
ExchangeNASDAQ
Beta-0.32
CurrencyUSD